The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
Clinical trial NCT05680870 · COMPLETED
Trial details
- NCT number
- NCT05680870
- Sponsor
- Aya Mohamed Sadek Elsaid
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-12-05
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.